MENU
+Compare
PLX
Stock ticker: ASE
AS OF
Jun 6, 11:26 AM (EDT)
Price
$1.55
Change
+$0.03 (+1.97%)
Capitalization
121M

PLX Protalix BioTherapeutics Forecast, Technical & Fundamental Analysis

Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx... Show more

PLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for PLX with price predictions
Jun 05, 2025

PLX's Stochastic Oscillator is staying in oversold zone for 5 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator entered the oversold zone -- be on the watch for PLX's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.

The Moving Average Convergence Divergence (MACD) for PLX just turned positive on June 03, 2025. Looking at past instances where PLX's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PLX advanced for three days, in of 253 cases, the price rose further within the following month. The odds of a continued upward trend are .

PLX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 183 cases where PLX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on May 28, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on PLX as a result. In of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

PLX moved below its 50-day moving average on May 09, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for PLX crossed bearishly below the 50-day moving average on May 14, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PLX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. PLX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.677) is normal, around the industry mean (16.332). P/E Ratio (30.400) is within average values for comparable stocks, (59.787). PLX's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.227). Dividend Yield (0.000) settles around the average of (0.040) among similar stocks. P/S Ratio (2.084) is also within normal values, averaging (263.647).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PLX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
PLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

PLX is expected to report earnings to fall 320.00% to 10 cents per share on August 18

Protalix BioTherapeutics PLX Stock Earnings Reports
Q2'25
Est.
$0.11
Q1'25
Missed
by $0.08
Q4'24
Est.
$0.10
Q3'24
Missed
by $0.03
Q2'24
Missed
by $0.05
The last earnings report on May 09 showed earnings per share of -5 cents, missing the estimate of 2 cents. With 45.17K shares outstanding, the current market capitalization sits at 121.00M.
A.I. Advisor
published General Information

General Information

a developer of recombinant therapeutic proteins

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Servicestothe Health Industry
Address
2 University Plaza
Phone
+1 201 696-9345
Employees
208
Web
https://www.protalix.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SMNNY14.790.05
+0.34%
Shimano Inc.
ITVPY10.31-0.03
-0.34%
ITV Plc.
RWEOY38.05-0.19
-0.50%
RWE AG
BLGO0.20N/A
-1.60%
BioLargo, Inc.
HESAF2680.78-54.24
-1.98%
Hermes International SA

PLX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, PLX has been loosely correlated with IOVA. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if PLX jumps, then IOVA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLX
1D Price
Change %
PLX100%
-5.00%
IOVA - PLX
50%
Loosely correlated
-1.91%
STOK - PLX
31%
Poorly correlated
-0.73%
ZNTL - PLX
31%
Poorly correlated
-2.00%
CPRX - PLX
31%
Poorly correlated
+0.28%
SNDX - PLX
31%
Poorly correlated
+1.82%
More